EDAP to Announce Second Quarter 2025 Financial Results on August 28, 2025
EDAP TMS (NASDAQ:EDAP), the global leader in robotic energy-based therapies, will release its Q2 2025 financial results on Thursday, August 28th, 2025, before market open.
The company will host a conference call and webcast at 8:30 AM EDT on the same day, featuring CEO Ryan Rhodes, CFO Ken Mobeck, and CAO François Dietsch. Investors can access the call via domestic (1-800-274-8461) or international (1-203-518-9814) numbers using passcode EDAP, or through the company's webcast platform.
EDAP TMS (NASDAQ:EDAP), leader mondiale nelle terapie robotiche basate sull'energia, pubblicherà i suoi risultati finanziari del secondo trimestre 2025 giovedì 28 agosto 2025, prima dell'apertura dei mercati.
La società terrà una conference call e una webcast alle 8:30 AM EDT dello stesso giorno, con la partecipazione del CEO Ryan Rhodes, del CFO Ken Mobeck e del CAO François Dietsch. Gli investitori potranno seguire la chiamata tramite i numeri nazionali (1-800-274-8461) o internazionali (1-203-518-9814) utilizzando il codice di accesso EDAP, oppure attraverso la piattaforma webcast dell'azienda.
EDAP TMS (NASDAQ:EDAP), líder mundial en terapias robóticas basadas en energía, publicará sus resultados financieros del segundo trimestre de 2025 el jueves 28 de agosto de 2025, antes de la apertura del mercado.
La compañía realizará una llamada conferencia y una transmisión en vivo a las 8:30 AM EDT del mismo día, con la participación del CEO Ryan Rhodes, el CFO Ken Mobeck y el CAO François Dietsch. Los inversores podrán acceder a la llamada a través de números nacionales (1-800-274-8461) o internacionales (1-203-518-9814) usando el código EDAP, o mediante la plataforma de webcast de la empresa.
EDAP TMS (NASDAQ:EDAP)는 로봇 에너지 기반 치료 분야의 글로벌 선두주자로, 2025년 2분기 재무 실적을 2025년 8월 28일 목요일, 시장 개장 전에 발표할 예정입니다.
회사는 같은 날 동부 표준시 오전 8시 30분에 CEO 라이언 로즈, CFO 켄 모벡, CAO 프랑수아 디에치가 참여하는 컨퍼런스 콜 및 웹캐스트를 진행합니다. 투자자들은 국내 전화번호(1-800-274-8461) 또는 국제 전화번호(1-203-518-9814)를 통해 EDAP 비밀번호를 사용하거나 회사의 웹캐스트 플랫폼을 통해 접속할 수 있습니다.
EDAP TMS (NASDAQ:EDAP), leader mondial des thérapies robotiques à base d'énergie, publiera ses résultats financiers du deuxième trimestre 2025 le jeudi 28 août 2025, avant l'ouverture des marchés.
L'entreprise organisera une conférence téléphonique et un webcast à 8h30 EDT le même jour, avec la participation du PDG Ryan Rhodes, du CFO Ken Mobeck et du CAO François Dietsch. Les investisseurs pourront accéder à l'appel via les numéros nationaux (1-800-274-8461) ou internationaux (1-203-518-9814) en utilisant le code d'accès EDAP, ou via la plateforme webcast de la société.
EDAP TMS (NASDAQ:EDAP), der weltweit führende Anbieter robotergestützter energie-basierter Therapien, wird seine Finanzergebnisse für das zweite Quartal 2025 am Donnerstag, den 28. August 2025, vor Börsenöffnung veröffentlichen.
Das Unternehmen veranstaltet am selben Tag um 8:30 Uhr EDT eine Telefonkonferenz und einen Webcast mit CEO Ryan Rhodes, CFO Ken Mobeck und CAO François Dietsch. Investoren können über nationale (1-800-274-8461) oder internationale (1-203-518-9814) Rufnummern mit dem Zugangscode EDAP teilnehmen oder die Webcast-Plattform des Unternehmens nutzen.
- None.
- None.
Company to host conference call and webcast on Thursday, August 28th at 8:30am EDT
AUSTIN, Texas, August 7, 2025 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that it will release its financial results for the second quarter ended June 30, 2025, before the markets open on Thursday, August 28th, 2025.
An accompanying conference call and webcast will be conducted by Ryan Rhodes, Chief Executive Officer, Ken Mobeck, Chief Financial Officer, and François Dietsch, Chief Accounting Officer. Please refer to the information below for conference call dial-in information and webcast registration.
Call Details:
Date: Thursday, August 28th
Time: 8:30 am EDT
Domestic: 1-800-274-8461
International: 1-203-518-9814
Passcode: EDAP
Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1726716&tp_key=220919ac3d
About EDAP TMS SA
A recognized leader in robotic energy-based therapies, EDAP TMS develops, manufactures, promotes and distributes worldwide minimally invasive medical devices for various conditions using ultrasound technology. By combining the latest technologies in imaging, robotics and precise non-invasive energy delivery, EDAP introduced the Focal One® in Europe and in the U.S. as the leading prostate focal therapy controlled by urologists with the potential to expand to multiple indications beyond prostate cancer. For more information on the Company, please visit https://focalone.com/.
Company Contact
Blandine Confort
Investor Relations / Legal Affairs
EDAP TMS SA
+33 4 72 15 31 50
bconfort@edap-tms.com
Investor Contact
John Fraunces
LifeSci Advisors, LLC
(917) 355-2395
jfraunces@lifesciadvisors.com
FAQ
When will EDAP (NASDAQ:EDAP) report Q2 2025 earnings?
How can investors join EDAP's Q2 2025 earnings call?
Who will present during EDAP's Q2 2025 earnings call?
What time is EDAP's Q2 2025 earnings conference call?
